Ulrich Platte is the founder of eTheRNA immunotherapies. eTheRNA immunotherapies has raised $104M in total funding. Latest round: Series B.
Ulrich Platte was appointed as the CFO of eTheRNA immunotherapies on June 3, 2019. He brings over 20 years of experience in financial management roles across life sciences, medical device, and pharmaceutical sectors, including previous CFO positions. Additionally, he has supported early-stage life science companies with financing and business development.
Full founder directory · Investor directory · Company funding database · Fundraising library